{"id":923369,"date":"2026-01-02T16:19:12","date_gmt":"2026-01-02T21:19:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/"},"modified":"2026-01-02T16:19:12","modified_gmt":"2026-01-02T21:19:12","slug":"evolent-reports-inducement-award-under-nyse-listing-rule-303a-08","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/","title":{"rendered":"Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n WASHINGTON<\/span>, Jan. 2, 2026<\/span> \/PRNewswire\/ — Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, announced that the Compensation Committee of Evolent’s Board of Directors approved the grant of a one-time time-based restricted stock unit award covering 587,500 shares of\u00a0Evolent Class A common stock, par value $0.01 per share (the “Inducement Award”), to Mr.\u00a0Mario Ramos\u00a0(“Mr. Ramos”), Evolent’s new Chief Financial Officer effective as of January 2, 2026. The Inducement Award was granted as an inducement material to Mr.\u00a0Ramos entering into employment with Evolent, as\u00a0Mr. Ramos\u00a0was neither previously an employee of Evolent nor a former employee returning upon a bona fide period of non-employment, in accordance with New York Stock Exchange Listing Rule 303A.08.<\/p>\n

The Inducement Award has a grant date value of $2,350,000, vesting 34% on the first anniversary of the grant date, 33% on the second anniversary of the grant date and 33% on the third anniversary of the grant date, contingent on his continued employment through the applicable vesting date.\u00a0<\/p>\n

\n

\n
\n \"Evolent
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n About Evolent\u00a0<\/b>\u00a0
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting\u00a0evolent.com.<\/p>\n

\n Media inquiries<\/b>\u00a0
Jamie Manfuso
media@evolent.com<\/a>\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/evolent-reports-inducement-award-under-nyse-listing-rule-303a08-302651815.html<\/a><\/p>\n

SOURCE Evolent Health, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire WASHINGTON, Jan. 2, 2026 \/PRNewswire\/ — Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, announced that the Compensation Committee of Evolent’s Board of Directors approved the grant of a one-time time-based restricted stock unit award covering 587,500 shares of\u00a0Evolent Class A common stock, par value $0.01 per share (the “Inducement Award”), to Mr.\u00a0Mario Ramos\u00a0(“Mr. Ramos”), Evolent’s new Chief Financial Officer effective as of January 2, 2026. The Inducement Award was granted as an inducement material to Mr.\u00a0Ramos entering into employment with Evolent, as\u00a0Mr. Ramos\u00a0was neither previously an employee of Evolent nor a former … <\/p>\n

Continue reading “Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-923369","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEvolent Reports Inducement Award Under NYSE Listing Rule 303A.08 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire WASHINGTON, Jan. 2, 2026 \/PRNewswire\/ — Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, announced that the Compensation Committee of Evolent’s Board of Directors approved the grant of a one-time time-based restricted stock unit award covering 587,500 shares of\u00a0Evolent Class A common stock, par value $0.01 per share (the “Inducement Award”), to Mr.\u00a0Mario Ramos\u00a0(“Mr. Ramos”), Evolent’s new Chief Financial Officer effective as of January 2, 2026. The Inducement Award was granted as an inducement material to Mr.\u00a0Ramos entering into employment with Evolent, as\u00a0Mr. Ramos\u00a0was neither previously an employee of Evolent nor a former … Continue reading "Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-02T21:19:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/473042\/Evolent_Health_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08\",\"datePublished\":\"2026-01-02T21:19:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\\\/\"},\"wordCount\":286,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/473042\\\/Evolent_Health_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\\\/\",\"name\":\"Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/473042\\\/Evolent_Health_Logo.jpg\",\"datePublished\":\"2026-01-02T21:19:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/473042\\\/Evolent_Health_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/473042\\\/Evolent_Health_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/","og_locale":"en_US","og_type":"article","og_title":"Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 - Market Newsdesk","og_description":"PR Newswire WASHINGTON, Jan. 2, 2026 \/PRNewswire\/ — Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, announced that the Compensation Committee of Evolent’s Board of Directors approved the grant of a one-time time-based restricted stock unit award covering 587,500 shares of\u00a0Evolent Class A common stock, par value $0.01 per share (the “Inducement Award”), to Mr.\u00a0Mario Ramos\u00a0(“Mr. Ramos”), Evolent’s new Chief Financial Officer effective as of January 2, 2026. The Inducement Award was granted as an inducement material to Mr.\u00a0Ramos entering into employment with Evolent, as\u00a0Mr. Ramos\u00a0was neither previously an employee of Evolent nor a former … Continue reading \"Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-02T21:19:12+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/473042\/Evolent_Health_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08","datePublished":"2026-01-02T21:19:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/"},"wordCount":286,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/473042\/Evolent_Health_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/","name":"Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/473042\/Evolent_Health_Logo.jpg","datePublished":"2026-01-02T21:19:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/473042\/Evolent_Health_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/473042\/Evolent_Health_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolent-reports-inducement-award-under-nyse-listing-rule-303a-08\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/923369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=923369"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/923369\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=923369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=923369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=923369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}